The results also showed that the expression inhibition of VEGFR2 partially reversed the impact of ECM1 overexpression on PS VII's intervention on ovarian cancer cell proliferation, angiogenesis, glycolysis, and other functions (Supplementary Figure 2B-F). This evidence concerns the gene ECM1 and ovarian cancer.